← All stocks

Aligos Therapeutics, Inc.

ALGS Net buying
CIK 0001799448 #4808 in the set updated 21 Sep 2026
Bought (120 mo)
$23.25M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$23.25M
+$23.25M against sales at will

By person

11 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Vivo Capital VIII, LLC entity
10% owner
$8.25M (2)
+$8.25M
3,547,030
56.87%
$2.68M
Nuechterlein Carole
Director
$6.00M (1)
+$6.00M
14,118,281
$10.68M
+356.6%
Novo Holdings A/S entity
10% owner
$3.00M (1)
+$3.00M
2,614,563
41.92%
$1.98M
Versant Venture Capital VI, L.P. entity
10% owner
$3.00M (1)
+$3.00M
3,292,339
52.79%
$2.49M
Woiwode Thomas
Director
$3.00M (1)
+$3.00M
866,896
13.90%
$656.07K
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
1,906,191
30.56%
$1.44M
BLATT LAWRENCE
President and CEO
1,866,092
29.92%
$1.41M
+89.9%
Beigelman Leonid
President
1,062,399
17.03%
$804.02K
+34.6%
Symons Julian A.
See Remarks
394,064
6.32%
$298.23K
+4.9%
Quan Lucinda Y.
See Remarks
384,805
6.17%
$291.22K
+2.5%
Scopa James Paul
Director
183,083
2.94%
$138.56K
Insider
Date
Role
Action
Shares
Price
Amount
Nuechterlein Carole
25 Oct 2023
Director
Buy indirect
7,933,601
$0.76
$6.00M
Versant Venture Capital VI, L.P.
20 Oct 2020
10% owner
Buy indirect
200,000
$15.00
$3.00M
Vivo Capital VIII, LLC
20 Oct 2020
10% owner
Buy indirect
66,733
$15.00
$1.00M
Vivo Capital VIII, LLC
20 Oct 2020
10% owner
Buy indirect
483,267
$15.00
$7.25M
Woiwode Thomas
20 Oct 2020
Director
Buy indirect
200,000
$15.00
$3.00M
Novo Holdings A/S
20 Oct 2020
10% owner
Buy
200,000
$15.00
$3.00M

What was left out

Form 4 filings counted 104
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 19,010,876
History held since 20 Oct 2020